(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CONVERGENT GENOMICS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CONVERGENT GENOMICS

ST13

US500000090146324

Class

44

Filing

90146324

Registration

6768915

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

35

Latest update

10/26/2024

Trademark type

Word

Nice classes

44

Filing date

08/28/2020

Registration date

06/21/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/21/2022

Last transaction

10/26/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2021-05-00

First use in commerce

2021-05-00

Drawing code

4

Owner type

03

Owner location

South San Francisco, CA

Examiner

CARROLL, DORITT

Law office

M70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Convergent Genomics, Inc.
Convergent Genomics, Inc.

Representatives

Sheila Fox Morrison DAVIS WRIGHT TREMAINE LLP

Technical classification

Nice Classes

Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 44

Medical testing for diagnostic or treatment purposes; medical diagnostic testingmonitoring and reporting services; providing cancer screening services

Publications

History of USPTO decisions and trademark events.

35 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/22/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/22/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/22/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/28/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/28/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/28/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

06/21/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

06/21/2022

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

05/17/2022

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

05/15/2022

SUPC

STATEMENT OF USE PROCESSING COMPLETE

04/13/2022

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

04/11/2022

IUAF

USE AMENDMENT FILED

03/18/2022

EISU

TEAS STATEMENT OF USE RECEIVED

03/18/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

10/07/2021

EX1G

SOU EXTENSION 1 GRANTED

10/05/2021

EXT1

SOU EXTENSION 1 FILED

10/05/2021

EEXT

SOU TEAS EXTENSION RECEIVED

10/05/2021

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

08/31/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/31/2021

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

08/31/2021

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

04/06/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/09/2021

PUBO

PUBLISHED FOR OPPOSITION

02/09/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/20/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/07/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/06/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/05/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/05/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/29/2020

GNRT

NON-FINAL ACTION E-MAILED

12/29/2020

CNRT

NON-FINAL ACTION WRITTEN

12/29/2020

DOCK

ASSIGNED TO EXAMINER

12/29/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/03/2020

NWAP

NEW APPLICATION ENTERED

09/01/2020

Continuous trademark protection

Get notified about every new filing that threatens CONVERGENT GENOMICS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.